Off-Label Use of Intravenous Immunoglobulin for Solid Organ Transplant Rejection: A Review of Clinical Effectiveness (Last Updated: Apr 30, 2018)
Project Line:
Health Technology Review
Current Filters
IVIG Evidence Bundle Remove
Off-Label Use of Intravenous Immunoglobulin for Non-Neurological Paraneoplastic Disorders: A Review of Clinical Effectiveness (Last Updated: Apr 30, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: A Review of Clinical Effectiveness (Last Updated: Mar 14, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Autoimmune or Inflammatory Conditions: A Review of Clinical Effectiveness (Last Updated: Apr 6, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: A Review of Clinical Effectiveness (Last Updated: Mar 23, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin: A Review of Clinical Effectiveness (Last Updated: Nov 1, 2017)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: A Review of Clinical Effectiveness (Last Updated: Apr 20, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Recurrent Spontaneous Abortion: A Review of Clinical Effectiveness (Last Updated: May 11, 2018)
Project Line:
Health Technology Review
Immunomodulatory Drugs and Intravenous Immunoglobulin (IVIg) for Patients with Chronic Demyelinating Polyneuropathy Who Are in Remission: A Review of Clinical and Cost-effectiveness and Guidelines (Last Updated: Mar 13, 2015)
Project Line:
Health Technology Review
Administration of Vaccines and Parenteral Medications in Home Care Settings: Safety and Guidelines (Last Updated: Mar 2, 2020)
Project Line:
Reference List